Rationale for targeting CD6 as a treatment for Sjögren's syndrome - Université de Bretagne Occidentale Access content directly
Conference Papers Year : 2013

Rationale for targeting CD6 as a treatment for Sjögren's syndrome

Renaudineau Yves
Immunologie et Pathologie
CV
Le Dantec Christelle
  • Function : Author
Immunologie et Pathologie
R. Alonso
  • Function : Author
E. Montero
  • Function : Author
Pierre Youinou
  • Function : Author
  • PersonId : 919888
Immunologie et Pathologie
Jacques-Olivier Pers
Immunologie et Pathologie

Domains

Immunology

Geneviève Michel  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-00806962

Submitted on : Tuesday, April 2, 2013-4:28:36 PM

Last modification on : Monday, March 28, 2022-12:10:04 PM

No file

Dates and versions

hal-00806962 , version 1 (02-04-2013)

Identifiers

  • HAL Id : hal-00806962 , version 1

Cite

Renaudineau Yves, Le Dantec Christelle, R. Alonso, E. Montero, Pierre Youinou, et al.. Rationale for targeting CD6 as a treatment for Sjögren's syndrome. 8th International Congress on Autoimmunity, Grenada, Spain, May 2013, Spain. ⟨hal-00806962⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST IMMUNO
34 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More